Dmitry Balyasny’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$747K Sell
7,265
-719,023
-99% -$46.8M ﹤0.01% 2357
2026
Q1
$34.5M Buy
726,288
+146,918
+25% +$6.59M 0.04% 482
2025
Q4
$18.4M Buy
579,370
+333,134
+135% +$10.4M 0.02% 758
2025
Q3
$6.93M Sell
246,236
-382,005
-61% -$11.6M 0.01% 1224
2025
Q2
$23.1M Buy
628,241
+567,481
+934% +$19.6M 0.03% 613
2025
Q1
$2.39M Buy
+60,760
New +$2.74M ﹤0.01% 1626
2024
Q4
Sell
-12,389
Closed -$560K 3274
2024
Q3
$560K Sell
12,389
-61,430
-83% -$2.92M ﹤0.01% 2213
2024
Q2
$3.64M Buy
73,819
+19,082
+35% +$778K 0.01% 1315
2024
Q1
$1.88M Sell
54,737
-97,891
-64% -$3.53M ﹤0.01% 1555
2023
Q4
$5.63M Sell
152,628
-47,385
-24% -$1.1M 0.01% 1076
2023
Q3
$4.05M Buy
200,013
+82,237
+70% +$1.81M 0.01% 1171
2023
Q2
$2.41M Sell
117,776
-596,752
-84% -$8.94M 0.01% 1322
2023
Q1
$10.8M Buy
714,528
+478,934
+203% +$10.6M 0.03% 743
2022
Q4
$5.61M Buy
235,594
+955
+0.4% +$27.7K 0.02% 977
2022
Q3
$8.27M Sell
234,639
-77,280
-25% -$3.28M 0.03% 769
2022
Q2
$10.9M Buy
+311,919
New +$11M 0.04% 621
2021
Q1
Sell
-20,464
Closed -$2.89M 2079
2020
Q4
$2.89M Buy
+20,464
New +$2.27M 0.02% 790

Other funds holding TWST

Dmitry Balyasny's TWST Position: Q2 2026 in Review

Dmitry Balyasny reduced its Twist Bioscience (TWST) stake by 99% in Q2 2026, selling an estimated $46.8M and leaving 7,265 shares worth $747K. The position accounts for ﹤0.01% of the portfolio, ranked #2357.

Dmitry Balyasny first reported a position in TWST in Q4 2020 and has held it in 17 quarters since. The position peaked at $34.5M in Q1 2026. 334 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Dmitry Balyasny held 7,265 shares of Twist Bioscience worth $747K as of Q2 2026.
  • Dmitry Balyasny sold 719,023 Twist Bioscience shares in Q2 2026, an estimated $46.8M.
  • Twist Bioscience made up ﹤0.01% of Dmitry Balyasny's portfolio in Q2 2026, its #2357 holding.
  • Dmitry Balyasny first reported a position in Twist Bioscience in Q4 2020 and has held it in 17 quarters since.
  • Dmitry Balyasny's Twist Bioscience position peaked at $34.5M in Q1 2026.
  • 334 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.